<<
>>

Morphine and the Hypodermic Syringe

The isolation of morphine from opium by F. W. A. Sertuener in 1805 marked the beginning of a new era in opium use. Physicians now had access to a purified active ingredient; hence, they were no longer un­certain of the strength of a dose and could investigate the effect of a specific amount.

Commercial produc­tion followed the isolation of morphine and by the 1830s morphine was commonly available in any area touched by pharmaceutical trade with Europe and the United States. Morphine was administered by mouth, clysis, or absorption through denuded skin, as after blistering. The refinement of the hypodermic syringe and needle at midcentury created a mode of delivery as revolutionary in the history of addiction as had been the isolation of morphine.

Hollow needles and syringes had been employed long before the appearance of the familiar syringe and needle in the nineteenth century, but the grow­ing number of purified chemicals, such as mor­phine, that could be directly injected into the body stimulated the pace of development and production. At first, injected morphine was considered less likely to be addictive than oral morphine because a smaller amount was required for equivalent pain relief. But by the 1870s this assumption was found to be erroneous, although many physicians contin­ued to use injected morphine for chronic ailments, such as arthritis.

<< | >>
Source: Kiple Kenneth F. (Editor). The Cambridge World History of Human Disease. Cambridge University Press,1993. — 1200 p.. 1993

More on the topic Morphine and the Hypodermic Syringe:

  1. Morphine and the Hypodermic Syringe
  2. Subject Index
  3. Kiple Kenneth F. (Editor). The Cambridge World History of Human Disease. Cambridge University Press,1993. — 1200 p., 1993